PFGIA
CHRS icon

Patriot Financial Group Insurance Agency’s Coherus Oncology CHRS Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,169
Closed -$14K – 499
2024
Q4 		$14K Hold
10,169
– – ﹤0.01% 479
2024
Q3 		$10.6K Hold
10,169
– – ﹤0.01% 499
2024
Q2 		$17.6K Buy
+10,169
New +$20.5K ﹤0.01% 473

Other funds holding CHRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Patriot Financial Group Insurance Agency's CHRS Position: Q1 2025 in Review

Patriot Financial Group Insurance Agency sold out of Coherus Oncology (CHRS) in Q1 2025, closing a stake of 10,169 shares — an estimated $14K sold.

Patriot Financial Group Insurance Agency first reported a position in CHRS in Q2 2024 and held it in 3 quarters. The position peaked at $17.6K in Q2 2024. 117 funds tracked by Wall St. Rank hold CHRS as of Q1 2025.

  • Patriot Financial Group Insurance Agency reported no remaining Coherus Oncology position as of Q1 2025 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 10,169 Coherus Oncology shares in Q1 2025, an estimated $14K.
  • Patriot Financial Group Insurance Agency first reported a position in Coherus Oncology in Q2 2024 and held it in 3 quarters.
  • Patriot Financial Group Insurance Agency's Coherus Oncology position peaked at $17.6K in Q2 2024.
  • 117 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2025.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2025, filed 14 Apr 2025.